Does GEMFIBROZIL Cause Hyperglycaemia? 28 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Hyperglycaemia have been filed in association with GEMFIBROZIL (Gemfibrozil). This represents 2.6% of all adverse event reports for GEMFIBROZIL.
28
Reports of Hyperglycaemia with GEMFIBROZIL
2.6%
of all GEMFIBROZIL reports
1
Deaths
4
Hospitalizations
How Dangerous Is Hyperglycaemia From GEMFIBROZIL?
Of the 28 reports, 1 (3.6%) resulted in death, 4 (14.3%) required hospitalization, and 1 (3.6%) were considered life-threatening.
Is Hyperglycaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GEMFIBROZIL. However, 28 reports have been filed with the FAERS database.
What Other Side Effects Does GEMFIBROZIL Cause?
Drug hypersensitivity (242)
Drug ineffective (77)
Rhabdomyolysis (63)
Fatigue (60)
Drug interaction (59)
Myalgia (58)
Nausea (54)
Acute kidney injury (52)
Diarrhoea (43)
Rash (41)
What Other Drugs Cause Hyperglycaemia?
INSULIN GLARGINE (1,903)
METFORMIN (1,626)
ALPELISIB (1,575)
DEXAMETHASONE (1,169)
PREDNISONE (1,135)
INSULIN LISPRO (743)
PREDNISOLONE (705)
INSULIN ASPART (646)
INSULIN HUMAN (620)
METHYLPREDNISOLONE (604)
Which GEMFIBROZIL Alternatives Have Lower Hyperglycaemia Risk?
GEMFIBROZIL vs GEMTUZUMAB OZOGAMICIN
GEMFIBROZIL vs GEMZAR
GEMFIBROZIL vs GENTAMICIN
GEMFIBROZIL vs GEODON
GEMFIBROZIL vs GILENYA